Hepatitis C and HIV: ribavirin plus interferon study recruiting.
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D015658:HIV Infections / Q000150:complications*; D006526:Hepatitis C / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D018579:Patient Selection; D012254:Ribavirin / Q000627:therapeutic use*; D014481:United States
D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin